Guidance language now reflects anticipation of FDA decision upon post-market study plan approval, compared to prior uncertainty about regulatory timing. The focus on US commercialization and sales ...

The “enhanced” form lays out the potential benefits — and risks — of listing off the MLS as the brokerage continues to tout ...